Sign Up to like & get
recommendations!
2
Published in 2023 at "Physiology"
DOI: 10.1152/physiol.2023.38.s1.5733411
Abstract: Thromboxane A2 (TxA2) is a potent coronary vasoconstrictor that has been implicated in promoting decreases in myocardial perfusion in a variety of (patho)-physiologic conditions. S18886 is a promising orally-active TxA2 receptor antagonist currently approved for…
read more here.
Keywords:
receptor antagonist;
s18886;
physiology;
receptor ... See more keywords